✦ LIBER ✦

Nuclear and flow cytometric characteristics associated with overexpression of the c-erbB-2 oncoprotein in breast carcinoma

✍ Scribed by D. N. Poller; M. Galea; D. Pearson; J. Bell; W. J. Gullick; C. W. Elston; R. W. Blamey; I. O. Ellis

Book ID: 105323186
Publisher: Springer US
Year: 1991
Tongue: English
Weight: 821 KB
Volume: 20
Category: Article
ISSN: 0167-6806
DOI: 10.1007/bf01833351

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

c-erbB-2 oncoprotein expression is assoc

c-erbB-2 oncoprotein expression is associated with poor prognosis in squamous cell carcinoma of the cervix

✍ Kuniyuki Oka; Takashi Nakano; Tatsuo Arai 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 559 KB

Proliferating cell nuclear antigen and c

Proliferating cell nuclear antigen and c-erbB-2 oncoprotein expression in adenoid cystic carcinomas of the salivary glands

✍ Kyung-Ja Cho; Seung-Sook Lee; Yong-Sik Lee 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 154 KB 👁 2 views

Background. Adenoid cystic carcinoma (ACC) of the salivary gland shows a variable clinical course. It would be helpful to discover reliable biologic markers in the management of patients with ACC. Methods. We examined proliferating cell nuclear antigen (PCNA) and c-erbB-2 oncoprotein expression on

Overexpression of c-erbB-2 protein corre

Overexpression of c-erbB-2 protein correlates with chromosomal gain at the c-erbB-2 locus and patient survival in advanced colorectal carcinomas

✍ Thomas Knösel; Youngwei Yu; Ulrike Stein; Holger Schwabe; Karsten Schlüns; Peter 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 230 KB

ErbB2 overexpression correlates with inc

ErbB2 overexpression correlates with increased expression of vascular endothelial growth factors A, C, and D in human breast carcinoma

✍ Wentao Yang; Kristine Klos; Ying Yang; Terry L. Smith; Daren Shi; Dihua Yu 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 858 KB

## Abstract ## BACKGROUND The angiogenic factor vascular endothelial growth factor (VEGF)‐A plays an important role in breast cancer progression. However, the involvement of VEGF‐C and VEGF‐D, two newer members of the VEGF family, in breast carcinoma and their relationship with clinicopathologic p

Cytoplasmic staining of c-erbB-2 is not

Cytoplasmic staining of c-erbB-2 is not associated with the presence of detectable c-erbB-2 mRNA in breast cancer specimens

✍ Susan L. Taylor; Angela Platt-Higgins; Philip S. Rudland; John H. R. Winstanley; 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 223 KB 👁 2 views

The cell-surface receptor tyrosine kinase protein c-erbB-2 is immunocytochemically detected as membrane staining on the surface of cancer cells in 20-30% of cases of breast cancer, and its presence has been associated with poor prognosis for the patient. However, there have been numerous reports of

Association of c-erbB2-gene amplificatio

Association of c-erbB2-gene amplification with poor prognosis in non-inflammatory breast carcinomas but not in carcinomas of the inflammatory type

✍ Monique G. Lě; Sétha Douc-Rasy; Jean Charles Ahomadegbe; Marc Spielmann; Martine 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 French ⚖ 701 KB

It is now accepted that c-erbB2-gene amplification is correlated with poor clinical outcome for patients, mainly when axillary nodes are invaded. We have confirmed this result by multivariate analysis in I78 patients with non-inflammatory breast cancer followed up for a mean period of 6.8 years (SD,